CREDIT SUISSE AG/ - ACLARIS THERAPEUTICS INC ownership

ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 82 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of ACLARIS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$678,883
-30.8%
99,107
+4.7%
0.00%0.0%
Q2 2023$981,458
+83.0%
94,644
+42.8%
0.00%0.0%
Q1 2023$536,302
-47.6%
66,292
+2.0%
0.00%0.0%
Q4 2022$1,023,309
+56.9%
64,972
+57.0%
0.00%0.0%
Q3 2022$652,000
+26.6%
41,392
+12.0%
0.00%0.0%
Q2 2022$515,000
-6.4%
36,942
+15.6%
0.00%
Q1 2022$550,000
+31.6%
31,952
+11.2%
0.00%
Q4 2021$418,000
-16.2%
28,730
+3.7%
0.00%
Q3 2021$499,000
+9.4%
27,692
+6.6%
0.00%
Q2 2021$456,000
+303.5%
25,967
-49.7%
0.00%
Q2 2019$113,000
-43.5%
51,593
+54.3%
0.00%
Q1 2019$200,000
-18.4%
33,440
+0.4%
0.00%
Q4 2018$245,000
-27.9%
33,306
+42.0%
0.00%
Q3 2018$340,000
-57.6%
23,457
-41.6%
0.00%
-100.0%
Q2 2018$802,000
+40.5%
40,182
+23.2%
0.00%0.0%
Q1 2018$571,000
-24.8%
32,619
+6.0%
0.00%0.0%
Q4 2017$759,000
+19.2%
30,760
+24.7%
0.00%0.0%
Q3 2017$637,000
+130.8%
24,674
+142.0%
0.00%
Q2 2017$276,000
-3.5%
10,197
+6.7%
0.00%
Q1 2017$286,000
-45.4%
9,560
-50.3%
0.00%
-100.0%
Q4 2016$524,00019,2510.00%
Other shareholders
ACLARIS THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Endurant Capital Management LP 1,769,785$1,911,0000.69%
Telemetry Investments, L.L.C. 214,593$232,0000.67%
Aisling Capital Management LP 634,455$685,0000.36%
Broadfin Capital, LLC 1,620,000$1,750,0000.32%
MFN Partners Management, LP 1,500,000$1,620,0000.24%
Sofinnova Investments, Inc. 1,911,573$2,064,0000.19%
Rock Springs Capital Management LP 2,974,754$3,213,0000.13%
Alambic Investment Management, L.P. 150,636$163,0000.12%
Cormorant Asset Management, LP 250,000$270,0000.02%
Man Group plc 3,734,793$4,034,0000.02%
View complete list of ACLARIS THERAPEUTICS INC shareholders